Hurun India Rich List 2026 edition
Rank#102- Wealth
- ₹32,900 Cr
- Company
- Biocon
2022 #68 2021 #53 2020 #34
Current companies 16 active board seats
Past companies 10 historical roles
Total affiliations 26 Since Nov 1993
Shareholding value •••• Premium profile
About Kiran Mazumdar Shaw
Data last updated:
Kiran Mazumdar Shaw has 32 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 16 companies, including Biocon Biologics Limited and Immuneel Therapeutics Private Limited. Formerly with 10 companies, such as Narayana Vaishno Devi Specialty Hospitals Private Limited and United Breweries Limited. Engaged in General Business, Technology. The 13 current companies with reported revenue have a combined latest revenue of ₹57,389 Cr; the largest is Trent Limited at ₹20,189 Cr (FY 2026).
Kiran Mazumdar-Shaw is #102 on the Hurun India Rich List 2026, with wealth of ₹32,900 Cr.
DIN 00347229
Primary Designation Whole-Time Director
First Appointment 18 Nov 1993
Oldest Company Age 73 yrs
Largest company Trent Limited · ₹20,189 Cr (FY 2026)
Combined revenue ₹57,389 Cr across 13 companies
Recognitions & Rankings
Hurun India Philanthropy List 2022 edition
Rank#89- Donation
- ₹7 Cr
- Main cause
- Environmental Sustainability
2021 #73 2020 #21
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Trent Limited L24240MH1952PLC008951 | Director | 01 Apr 2024 | 1952 | ₹20,189 Cr (FY 2026) | Active |
 Biocon Limited L24234KA1978PLC003417 | Whole-Time Director | 01 Apr 2010 | 1978 | ₹16,470 Cr (FY 2025) | Active |
| Biocon Biologics Limited U24119KA2016PLC093936 | Whole-Time Director | 08 Jun 2016 | 2016 | ₹10,144 Cr (FY 2025) | Active |
 Narayana Hrudayalaya Limited L85110KA2000PLC027497 | Director | 06 Feb 2008 | 2000 | ₹5,575 Cr (FY 2025) | Active |
 Syngene International Limited L85110KA1993PLC014937 | Director | 18 Nov 1993 | 1993 | ₹3,714 Cr (FY 2025) | Active |
| Biocon Pharma Limited U24232KA2014PLC077036 | Director | 31 Oct 2014 | 2014 | ₹982 Cr (FY 2025) | Active |
| Biocon Research Limited U73100KA2008PLC046583 | Director | 28 May 2008 | 2008 | ₹247 Cr (FY 2019) | Active |
 Csep Research Foundation U74999DL2013NPL248687 | Director | 09 Nov 2021 | 2013 | ₹23.95 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Narayana Vaishno Devi Specialty Hospitals Private Limited U85110KA2014PTC076218 | Director | 05 Sep 2014 | 2014 | ₹42 Lakh (FY 2025) | Active |
 United Breweries Limited L36999KA1999PLC025195 | Director | 26 Oct 2009 | 1999 | ₹19,444 Cr (FY 2025) | Active |
 Infosys Limited L85110KA1981PLC013115 | Director | 10 Jan 2014 | 1981 | ₹182,972 Cr (FY 2026) | Active |
 Invest Karnataka Forum U74999KA2016NPL095481 | Nominee Director | 23 Aug 2016 | 2016 | ₹35.16 Cr (FY 2024) | Active |
 Indian School Of Business U80100TG1997NPL036631 | Director | 08 Apr 2006 | 1997 | ₹772 Cr (FY 2025) | Active |
 Glenloch Properties Private Limited U70200KA2010PTC052807 | Director | 09 Mar 2010 | 2010 | – | Converted To Llp |
| Narayana Institute For Advanced Research Private Limited U85121KA2006PTC040989 | Director | 17 Jan 2007 | 2006 | ₹17.7 Lakh (FY 2022) | Dissolved Under Section 59(8) |
| Biocon Biopharmaceuticals Limited U24231KA2002PLC030643 | Managing Director | 17 Jun 2002 | 2002 | – | Amalgamated |
| Biofusion Therapeutics Limited U73100KA2021PLC145487 | Director | 18 Mar 2021 | 2021 | ₹56.53 Cr (FY 2023) | Amalgamated |
| Clinigene International Limited U85195KA2000PLC027566 | Director | 04 Aug 2000 | 2000 | ₹44.41 Cr (FY 2014) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Biocon Biologics Limited
Immuneel Therapeutics Private Limited
Biocon Biopharmaceuticals Limited
Biocon Pharma Limited
Premium access
Shareholding and investment profile for Kiran Mazumdar Shaw
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kiran Mazumdar Shaw
Kiran Mazumdar Shaw has 32 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 16 companies, including Biocon Biologics Limited and Immuneel Therapeutics Private Limited. Formerly with 10 companies, such as Narayana Vaishno Devi Specialty Hospitals Private Limited and United Breweries Limited. Engaged in General Business, Technology. The 13 current companies with reported revenue have a combined latest revenue of ₹57,389 Cr; the largest is Trent Limited at ₹20,189 Cr (FY 2026).
Kiran Mazumdar Shaw is associated with 16 companies as Whole-Time Director and Director, including Trent Limited (₹20,189 Cr), Biocon Limited (₹16,470 Cr), Biocon Biologics Limited (₹10,144 Cr).
Kiran Mazumdar Shaw has expertise in General Business, Technology.
Kiran Mazumdar Shaw has 32 years in corporate governance.
By reported revenue, the largest current company of Kiran Mazumdar Shaw is Trent Limited, with revenue of ₹20,189 Cr (FY 2026).
The 13 current companies of Kiran Mazumdar Shaw that report revenue have a combined latest revenue of ₹57,389 Cr.
Kiran Mazumdar Shaw currently holds positions at 16 companies; the 5 largest by reported revenue are Trent Limited (₹20,189 Cr), Biocon Limited (₹16,470 Cr), Biocon Biologics Limited (₹10,144 Cr), Narayana Hrudayalaya Limited (₹5,575 Cr), Syngene International Limited (₹3,714 Cr).